Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
+10.74%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$84.7B
AUM Growth
+$3.15B
(+3.9%)
Cap. Flow
-$3.42B
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
10.93%
Holding
2,551
New
35
Increased
617
Reduced
853
Closed
517
Top Buys
| 1 |
L3Harris
LHX
|
+$119M |
| 2 |
Danaher
DHR
|
+$116M |
| 3 |
Zebra Technologies
ZBRA
|
+$111M |
| 4 |
West Pharmaceutical
WST
|
+$87.2M |
| 5 |
Assurant
AIZ
|
+$87M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$196M |
| 2 |
Microsoft
MSFT
|
+$189M |
| 3 |
Merck
MRK
|
+$147M |
| 4 |
Mastercard
MA
|
+$130M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$124M |
Sector Composition
| 1 | Technology | 21.39% |
| 2 | Healthcare | 15.17% |
| 3 | Financials | 13.51% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
LendingClub
LC
$1.91B
| $437K | ﹤0.01% |
49,677
-38,974
| -44% | -$343K |
|
1477
Universal Insurance Holdings
UVE
$719M
| $437K | ﹤0.01% |
41,300
| – | – |
|
1478
Materials Select Sector SPDR Fund
XLB
$5.5B
| $425K | ﹤0.01% |
5,465
| – | – |
|
1479
SolarEdge
SEDG
$1.72B
| $409K | ﹤0.01% |
1,444
+317
| +28% | +$89.7K |
|
|
LSXMK
1480
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $405K | ﹤0.01% |
13,359
| – | – |
|
1481
Liberty Global Class A
LBTYA
$4.05B
| $399K | ﹤0.01% |
21,058
-5,378
| -20% | -$102K |
|
|
GTY
1482
Getty Realty Corp
GTY
$1.6B
| $396K | ﹤0.01% |
11,702
-2,736
| -19% | -$92.6K |
|
1483
Twilio
TWLO
$15.7B
| $395K | ﹤0.01% |
8,061
-8,589
| -52% | -$420K |
|
1484
Teva Pharmaceuticals
TEVA
$22.9B
| $393K | ﹤0.01% |
43,140
+6,483
| +18% | +$59.1K |
|
1485
SiriusXM
SIRI
$7.84B
| $390K | ﹤0.01% |
6,671
-7,613
| -53% | -$445K |
|
1486
XPeng
XPEV
$19.9B
| $389K | ﹤0.01% |
39,163
| – | – |
|
1487
Ero Copper
ERO
$1.75B
| $382K | ﹤0.01% |
+27,737
| New | +$382K |
|
1488
Revvity
RVTY
$9.62B
| $382K | ﹤0.01% |
2,721
+158
| +6% | +$22.2K |
|
1489
Sleep Number
SNBR
$214M
| $379K | ﹤0.01% |
14,600
-855
| -6% | -$22.2K |
|
1490
VF Corp
VFC
$5.8B
| $379K | ﹤0.01% |
13,712
+3,369
| +33% | +$93K |
|
1491
InvenTrust Properties
IVT
$2.33B
| $372K | ﹤0.01% |
18,724
+2,900
| +18% | +$57.6K |
|
1492
Vanguard FTSE Developed Markets ETF
VEA
$174B
| $372K | ﹤0.01% |
8,860
-25,410
| -74% | -$1.07M |
|
1493
Royalty Pharma
RPRX
$15.7B
| $364K | ﹤0.01% |
9,223
+2,145
| +30% | +$84.8K |
|
1494
Iovance Biotherapeutics
IOVA
$821M
| $361K | ﹤0.01% |
56,509
-7,347
| -12% | -$46.9K |
|
1495
Brown & Brown
BRO
$30.9B
| $361K | ﹤0.01% |
6,336
-1,235
| -16% | -$70.3K |
|
|
ALEX
1496
Alexander & Baldwin
ALEX
$1.34B
| $360K | ﹤0.01% |
19,231
-5,862
| -23% | -$110K |
|
1497
VEON
VEON
$3.71B
| $359K | ﹤0.01% |
29,291
| – | – |
|
1498
Qiagen
QGEN
$9.82B
| $355K | ﹤0.01% |
6,704
+3,944
| +143% | +$209K |
|
1499
Enbridge
ENB
$107B
| $349K | ﹤0.01% |
8,937
| – | – |
|
1500
Atea Pharmaceuticals
AVIR
$249M
| $337K | ﹤0.01% |
70,000
-1,504
| -2% | -$7.24K |
|